Comparative pharmacology of newer progestogens (Q34397243)

1 August 2017

1 reference

title

Comparative pharmacology of newer progestogens (English)

1 reference

1 August 2017

1 reference

H Kuhl

1

1 reference

1 August 2017

1 February 1996

1 reference

1 August 2017

1 reference

1 August 2017

51

1 reference

1 August 2017

2

1 reference

1 August 2017

188-215

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199651020-00002

1 August 2017

0 references

cites work

Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins

1 reference

12 December 2020

Biotransformation of norgestimate in women

1 reference

12 December 2020

Short- and long-term effects on lipid metabolism of oral contraceptives containing 30 micrograms ethinylestradiol and 150 micrograms desogestrel or 3-keto-desogestrel

1 reference

12 December 2020

A comparative study on the effects of a monophasic pill containing desogestrel plus 20 μg ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors

1 reference

12 December 2020

Six-month carbohydrate metabolism studies in women using oral contraceptives containing gestodene and ethinyl estradiol

1 reference

12 December 2020

Comparison of two triphasic contraceptives with different progestogens: effects on metabolism and coagulation proteins

1 reference

12 December 2020

Contraceptives containing desogestrel or levonorgestrel have different effects on serum lipoproteins and post-heparin plasma lipase activities

1 reference

12 December 2020

The pharmacological profile of norgestimate, a new orally active progestin

1 reference

12 December 2020

The cellular mechanism of the antiandrogenic action of nomegestrol acetate, a new 19-nor progestagen, on the rat prostate

1 reference

12 December 2020

Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins

1 reference

12 December 2020

Effect of nomegestrol acetate on spinability, ferning and mesh dimension of midcycle cervical mucus

1 reference

12 December 2020

Enhanced generation and resolution of fibrin in women above the age of 30 years using oral contraceptives low in estrogen

1 reference

12 December 2020

Selective inhibition of protein disulfide isomerase by estrogens.

1 reference

12 December 2020

Intra- and interindividual variations in contraceptive steroid levels during 12 treatment cycles: no relation to irregular bleedings

1 reference

12 December 2020

Effect of two oral contraceptives containing 30 micrograms ethinylestradiol and 75 micrograms gestodene or 150 micrograms desogestrel upon various hormonal parameters

1 reference

12 December 2020

Metabolic effects of three new low-dose pills: a six-month experience

1 reference

12 December 2020

Effects of two progestins with different androgenic properties on hepatic endothelial lipase and high density lipoprotein2

1 reference

12 December 2020

Comparative progestational and androgenic activity of norgestimate and levonorgestrel in the rat

1 reference

12 December 2020

Effects of norgestimate in combination with ethinyl estradiol on cervical mucus

1 reference

12 December 2020

A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel

1 reference

12 December 2020

The affinity of norgestimate for uterine progestogen receptors and its direct action on the uterus

1 reference

12 December 2020

Metabolism of the contraceptive steroid desogestrel by human liver in vitro

1 reference

12 December 2020

Metabolism of the contraceptive steroid desogestrel by the intestinal mucosa

1 reference

12 December 2020

Effects of three types of combined O.C. pills on blood coagulation, fibrinolysis and platelet function

1 reference

12 December 2020

Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels i

1 reference

12 December 2020

The pharmacological profile of TX 066 (17 alpha-acetoxy-6-methyl-19-nor-4,6-pregna-diene-3,20-dione), a new oral progestative.

1 reference

12 December 2020

Plasma concentrations of 3-keto-desogestrel after oral administration of desogestrel and intravenous administration of 3-keto-desogestrel

1 reference

12 December 2020

The metabolism of megestrol acetate (17-alpha-acetoxy-6-methylpregna-4,6-diene-3,20-dione) in women

1 reference

12 December 2020

Metabolic changes during treatment with two different progestogens

1 reference

12 December 2020

Interaction of [3H]nomegestrol acetate with cytosolic progesterone receptors from the rat uterus

1 reference

12 December 2020

Extinction of mineralocorticoid effects in 19-norprogesterone derivatives: structure-activity relationships

1 reference

12 December 2020

Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone

1 reference

12 December 2020

Systemic availability of levonorgestrel after single oral administration of a norgestimate-containing combination oral contraceptive to 12 young women

1 reference

12 December 2020

Effects of 180 micrograms and 250 micrograms norgestimate on pituitary-ovarian function and cervical mucus

1 reference

12 December 2020

Serum levels of 3-keto-desogestrel after oral administration of desogestrel and 3-keto-desogestrel

1 reference

12 December 2020

Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women

1 reference

12 December 2020

Insulin resistance, secretion, and metabolism in users of oral contraceptives

1 reference

12 December 2020

Prodrug versus drug effects of 150 micrograms desogestrel or 3-keto-desogestrel in combination with 30 micrograms ethinylestradiol on hormonal parameters: relevance of the peak serum level of 3-keto-desogestrel

1 reference

12 December 2020

A comparison of the potencies and activities of progestogens used in contraceptives

1 reference

12 December 2020

Comparative progestational activity of norgestimate, levonorgestrel-oxime and levonorgestrel in the rat and binding of these compounds to the progesterone receptor.

1 reference

12 December 2020

Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration

1 reference

12 December 2020

Receptor binding of norgestimate--a new orally active synthetic progestational compound

1 reference

12 December 2020

Effects of two triphasic oral contraceptives containing ethinylestradiol plus levonorgestrel or gestodene on blood coagulation and fibrinolysis

1 reference

12 December 2020

Is the contraceptive effect of 300 micrograms of norethisterone mainly peripheral or central?

1 reference

12 December 2020

The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.

1 reference

12 December 2020

Enzyme immunoassay for nomegestrol acetate in human plasma

1 reference

12 December 2020

Effects of nomegestrol acetate (5 mg/d) on hormonal, metabolic and hemostatic parameters in premenopausal women

1 reference

12 December 2020

Pharmacokinetics of oestrogens and progestogens

1 reference

12 December 2020

Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters

1 reference

12 December 2020

Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women

1 reference

12 December 2020

A comparison of the effects of two triphasic oral contraceptives on haemostasis

1 reference

12 December 2020

Post-menopausal hormone replacement therapy: effects of progestogens on serum lipids and lipoproteins. A review

1 reference

12 December 2020

Effects of the new progestagen STS 557 on the biosynthesis of steroids in tissue slices of the human ovary

1 reference

12 December 2020

Enhanced hepatic extraction of estrogens used for replacement therapy.

1 reference

12 December 2020

Effect on lipid metabolism of a biphasic desogestrel-containing oral contraceptive: divergent changes in apolipoprotein B and E and transitory decrease in Lp(a) levels

1 reference

12 December 2020

Effect of the menstrual cycle, oral contraception and pregnancy on forearm blood flow, venous distensibility and clotting factors

1 reference

12 December 2020

Radioimmunoassay of a new progestagen, Org 2969, and its metabolite

1 reference

12 December 2020

A multicentre study of coagulation and haemostatic variables during oral contraception: variations with four formulations. Task Force on Oral Contraceptives--WHO Special Programme of Research, Development and Research Training in Human Reproduction,

1 reference

12 December 2020

Update on the metabolic effects of steroidal contraceptives and their relationship to cardiovascular disease risk

1 reference

12 December 2020

The effects of the addition of nomegestrol acetate to post-menopausal oestrogen therapy

1 reference

12 December 2020

Effect of Oral Contraceptives on Plasma Androgenic Steroids and Their Precursors

1 reference

12 December 2020

Excessive deposition of fibrin, platelets and platelet thrombi on vascular subendothelium during contraceptive drug treatment

1 reference

12 December 2020

[Radioimmunologic determination of the progestagen dienogest in plasma and saliva]

1 reference

12 December 2020

Metabolism of a new synthetic progestagen, Org 2969, by human liver in vitro

1 reference

12 December 2020

Serum levels of 3-keto-desogestrel and SHBG during 12 cycles of treatment with 30 micrograms ethinylestradiol and 150 micrograms desogestrel

1 reference

12 December 2020

Pharmacologic and pharmacokinetic characteristics of norgestimate and its metabolites

1 reference

12 December 2020

Gestodene: a novel synthetic progestin--characterization of binding to receptor and serum proteins

1 reference

12 December 2020

A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.

1 reference

12 December 2020

Effect of nomegestrol acetate, a new 19-nor-progesterone derivative, on pituitary-ovarian function in women.

1 reference

12 December 2020

Evaluation of a new generation of oral contraceptives. The Advisory Board for the New Progestins

1 reference

12 December 2020

Carbohydrate metabolism studies after one year of using an oral contraceptive containing gestodene and ethinyl estradiol.

1 reference

12 December 2020

Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene

1 reference

12 December 2020

Regulation of rat uterine steroid receptors by nomegestrol acetate, a new 19-nor-progesterone derivative

1 reference

12 December 2020

PERIPHERAL VENOUS DISTENSIBILITY AND VELOCITY OF VENOUS BLOOD FLOW DURING PREGNANCY OR DURING ORAL CONTRACEPTIVE THERAPY

1 reference

12 December 2020

Coagulation effects of oral contraception

1 reference

12 December 2020

Androgenic, anabolic, estrogenic and antiestrogenic effects of desogestrel and lynestrenol: Effects on serum proteins and vaginal cytology

1 reference

12 December 2020

Lipid metabolic studies in oophorectomized women. Effects induced by the addition of norethisterone acetate to two different oestrogens on serum individual phospholipids and serum lecithin fatty acid composition

1 reference

12 December 2020

The effect of a biphasic desogestrel-containing oral contraceptive on carbohydrate metabolism and various hormonal parameters.

1 reference

12 December 2020

Effect of seven low-dose combined oral contraceptive preparations on carbohydrate metabolism.

1 reference

12 December 2020

Time-dependent alterations in lipid metabolism during treatment with low-dose oral contraceptives

1 reference

12 December 2020

Serum distribution of two contraceptive progestins: 3-ketodesogestrel and gestodene

1 reference

12 December 2020

The selectivity of a new progestin

1 reference

12 December 2020

Potency and pharmacokinetics of gestagens

1 reference

12 December 2020

Metabolism of norgestimate by human gastrointestinal mucosa and liver microsomes in vitro

1 reference

12 December 2020

Pharmacokinetics of gestodene in 12 women who received a single oral dose of 0.075 mg gestodene and, after a wash-out phase, the same dose during one treatment cycle

1 reference

12 December 2020

Effects of nomegestrol acetate on carbohydrate metabolism.

1 reference

12 December 2020

[The endocrinologic profile of metabolites of the progestin dienogest]

1 reference

12 December 2020

Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone

1 reference

12 December 2020

Interaction of new 19 nor progesterone derivatives with progestagen, mineralocorticoid and glucocorticoid cytosolic receptors

1 reference

12 December 2020

Alterations in the serum levels of gestodene and SHBG during 12 cycles of treatment with 30 micrograms ethinylestradiol and 75 micrograms gestodene

1 reference

12 December 2020

Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives

1 reference

12 December 2020

10.2165/00003495-199651020-00002

Identifiers

DOI

1 reference

PubMed ID

8808163

Dimensions Publication ID

1 August 2017

0 references

1 reference

PubMed ID

8808163